Viveon Health Acquisition filed a preliminary proxy outlining its proposed merger with Suneva Medical at a pro forma equity valuation (assuming no share redemptions) of approximately $511 million.
If approved, Suneva is expected to list on the NYSE under the symbol RNEW.
Under terms of the proposed transaction announced less than two weeks ago, VHAQ will issue 25 million shares to current security holders of Suneva. Suneva stockholders may also receive up to 12 million earn out shares if certain stock price thresholds are met.
VHAQ raised approximately $201 million in its IPO.
Suneva is based in San Diego, CA, and develops regenerative aesthetics solutions. Read more.
